Successfully accounting for gaps in data could help scientists understand how to develop better treatment strategies that can be initiated shortly after birth.
Source: HIV/AIDS news from Medical News Today
streeck
Pre-exposure prophylaxis, used to prevent HIV, found to be as safe as aspirin
Pre-exposure prophylaxis, or PrEP, is the first medicine approved by the Food and Drug Administration that has been shown to be effective for preventing HIV infection.
Source: HIV/AIDS news from Medical News Today
Can we improve acceptance of HIV testing?
How you offer patients an HIV test has a significant impact on the likelihood of them accepting tests, finds a study published by The BMJ.
Source: HIV/AIDS news from Medical News Today
Synthetic biologists use bacterial superglue for faster vaccine development
An interdisciplinary team of Oxford University researchers has devised a new technique to speed up the development of novel vaccines.Many vaccines are based around virus-like particles (VLPs).
Source: HIV/AIDS news from Medical News Today
Scientists uncover how part of a protein helps primates fight HIV
The discovery could provide a target for future anti-HIV gene therapy.Scientists have uncovered part of a protein found in humans and other primates that can help us fight off HIV.
Source: HIV/AIDS news from Medical News Today
Preventing HIV infection with prophylactic drugs important to reversing HIV epidemic among men who have sex with men in the UK
The use of antiretroviral therapy (ART) taken as pre-exposure prophylaxis (PrEP)1 could lead to a marked decline in HIV incidence – the annual rate of infection – among men who have sex with men…
Source: HIV/AIDS news from Medical News Today
Quick screening method identifies promising anti-Ebola drugs
A quick screening method has been used for the first time in a standard open laboratory to identify and test promising anti-Ebola drugs.
Source: HIV/AIDS news from Medical News Today
ABIVAX announces positive top-line clinical Phase IIa data for novel HIV drug-candidate ABX464
ABIVAX, an emerging leader in developing and commercializing novel antiviral therapies for diseases like HIV/AIDS and chronic Hepatitis B (CHB), today announced positive top-line efficacy and…
Source: HIV/AIDS news from Medical News Today
IU School of Medicine, BC Centre for Excellence in HIV/AIDS confront Indiana HIV outbreak
The Indiana University School of Medicine and the BC Centre for Excellence in HIV/AIDS have joined forces to respond to a highly concentrated HIV epidemic driven by the injection of prescription…
Source: HIV/AIDS news from Medical News Today
Racial disparity lies at intersection of HIV, Hodgkin lymphoma
A new study finds a significant racial disparity within a doubly troubled population of patients: those with HIV and Hodgkin lymphoma.
Source: HIV/AIDS news from Medical News Today